ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $256,000 | -2.3% | 9,111 | -9.7% | 0.00% | – |
| Q4 2020 | $262,000 | -73.7% | 10,087 | -68.1% | 0.00% | -100.0% |
| Q1 2020 | $998,000 | -45.5% | 31,655 | +3.1% | 0.00% | -50.0% |
| Q4 2019 | $1,831,000 | -36.6% | 30,712 | -61.0% | 0.00% | -33.3% |
| Q3 2019 | $2,890,000 | +3.1% | 78,845 | +30.9% | 0.00% | 0.0% |
| Q2 2019 | $2,803,000 | +20.2% | 60,249 | +14.7% | 0.00% | +50.0% |
| Q3 2018 | $2,331,000 | +106.6% | 52,544 | +82.6% | 0.00% | +100.0% |
| Q2 2018 | $1,128,000 | -45.9% | 28,775 | -0.1% | 0.00% | -50.0% |
| Q1 2018 | $2,084,000 | +29.9% | 28,812 | +18.2% | 0.00% | 0.0% |
| Q4 2017 | $1,604,000 | -18.2% | 24,367 | +1.6% | 0.00% | 0.0% |
| Q2 2015 | $1,961,000 | +22.9% | 23,980 | +39.2% | 0.00% | 0.0% |
| Q1 2015 | $1,595,000 | – | 17,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $99,609,000 | 22.32% |
| Bellevue Group AG | 5,465,715 | $203,160,000 | 2.81% |
| Rhenman & Partners Asset Management AB | 455,000 | $16,912,000 | 1.50% |
| Endurant Capital Management LP | 135,901 | $5,051,000 | 1.49% |
| Boxer Capital, LLC | 975,000 | $36,241,000 | 1.25% |
| DCF Advisers, LLC | 56,500 | $2,100,000 | 1.07% |
| Pentwater Capital Management LP | 2,169,022 | $80,623,000 | 1.04% |
| Nicholas Investment Partners, LP | 235,855 | $8,767,000 | 0.95% |
| Amia Capital LLP | 20,464 | $761,000 | 0.88% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,717,000 | 0.83% |